AwardFind

6505--Latanoprost Ophthalmic Solution (VA-27-00006027)

Solicitation · Department of Veterans Affairs · Responses due Nov 17, 2026

6505--Latanoprost Ophthalmic Solution (VA-27-00006027) is a solicitation posted on SAM.gov by Department of Veterans Affairs (Nac Pharmaceuticals (36e797)) on Oct 30, 2026, under NAICS 325412 (Pharmaceutical Preparation Manufacturing). No small business set-aside is listed. Responses are due Nov 17, 2026.

Notice type
Solicitation
Office
Veterans Affairs, Department of / Nac Pharmaceuticals (36e797)
Solicitation number
36E79727R0039
Set-aside
None listed
Place of performance
Not stated
Posted
Oct 30, 2026
Responses due
Nov 17, 2026 (16 days left)

The full description, attachments and response instructions are on SAM.gov: read this notice on SAM.gov. To respond you need an active SAM.gov registration, which is free.

What this solicitation means

A solicitation (an RFP, RFQ or IFB) asks businesses to submit bids, quotes or proposals. Your response is an offer the agency can accept and turn into a contract.

  1. Read the full solicitation and every attachment on SAM.gov, including the scope of work and evaluation criteria.
  2. Confirm you are eligible: active SAM.gov registration, the NAICS size standard and any set-aside.
  3. Submit questions to the contracting officer before the question deadline, if there is one.
  4. Prepare your response exactly as instructed and submit it before the deadline.

Who wins pharmaceutical preparation manufacturing government contracts

Federal agencies obligated $37.7B on contracts under NAICS 325412 from FY2024 to FY2026, including $14.5B in FY2026. The largest contractors in this industry, possible competitors or teaming partners for this bid:

  1. McKesson Corporation: $34.3B
  2. Bavarian Nordic A/S: $463M
  3. Emergent Biosolutions Canada Inc: $356M
  4. Alvogen, Inc.: $285M
  5. Dla Troop Support: $254M

Recent pharmaceutical preparation manufacturing contract awards

Recent contract awards under NAICS 325412
Start dateRecipientAgency and descriptionAmountRecord
Sep 30, 2026Southernbelle Room, LLCDepartment of Health and Human ServicesBULK PHRAMA REPLENISHMENT 2$6,192,20075A50326C00014
Sep 30, 2026Lovell Government Services Inc.Department of Health and Human ServicesPROCUREMENT OF POTASSIUM IODIDE$33,12075A50326C00013
Sep 30, 2026Hikma Pharmaceuticals USA Inc.Department of Health and Human ServicesFY26 SNS PHARMACEUTICAL LOGISTIC REPLENISHMENT - DIAZEPAM$7,521,32575A50326C00012
Sep 30, 2026The Stronghold Group LLCDepartment of Health and Human ServicesBULK PHARMACEUTICAL BUY FOR SNS WAREHOUSES (THE STRONGHOLD GROUP LLC)$6,686,76075A50326C00011
Sep 30, 2026Paragon Enterprises IncDepartment of Health and Human ServicesBULK PHARMACEUTICAL BUY FOR SNS WAREHOUSES (PARAGON ENTERPRISES INC.)$237,60075A50326C00009

More: government pharmaceutical preparation manufacturing contracts · NAICS 325412

VA contract spending

The Department of Veterans Affairs obligated $229B on contracts from FY2024 to FY2026. Its largest contractors were Optum Public Sector Solutions, Inc., McKesson Corporation, Triwest Healthcare Alliance Corp. What it buys most: direct health and medical insurance carriers, pharmaceutical preparation manufacturing, offices of physicians (except mental health specialists).

See Department of Veterans Affairs contracts: top contractors, what it buys and recent awards.

Similar open bids: pharmaceutical preparation manufacturing

More open government contracts

Guides for this bid

Frequently asked questions

When is the response deadline for 36E79727R0039?
Responses are due Nov 17, 2026. Always confirm the date and time zone in the notice on SAM.gov, since agencies sometimes extend deadlines with an amendment.
Who can respond to 6505--Latanoprost Ophthalmic Solution (VA-27-00006027)?
No set-aside is listed, so any responsible business registered in SAM.gov can respond, large or small. Registration is free.
Who usually wins pharmaceutical preparation manufacturing government contracts?
Under NAICS 325412, the largest federal contractors from FY2024 to FY2026 were McKesson Corporation ($34.3B), Bavarian Nordic A/S ($463M), Emergent Biosolutions Canada Inc ($356M).

Source: SAM.gov Contract Opportunities, last checked Nov 1, 2026. Independent website. Not affiliated with any government agency.